J&J | JNJ - Interest Income


J&J reported $2.27 in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
AbbVie USD 72M 13M Mar/2026
Abbott USD 106M 28M Mar/2026
AstraZeneca USD 80M 7M Jun/2026
Baxter International USD 12M 1000K Mar/2026
Bayer EUR 169M 39M Dec/2025
Becton, Dickinson and Co. USD 9M 5M Mar/2026
Biogen USD 37.9M 700K Mar/2026
Boston Scientific USD 4M 3M Dec/2022
Dexcom USD 19.5M 4M Mar/2026
Edwards Lifesciences USD 56.3M 17.7M Dec/2025
Eli Lilly USD 65M 25M Sep/2025
Gilead Sciences USD 95M 0 Mar/2026
GlaxoSmithKline GBP 22M 96M Mar/2026
Globus Medical USD 815K 3.08M Dec/2024
Insulet USD 4.9M 800K Mar/2026
Integra LifeSciences USD 4.11M 256K Mar/2026
Intuitive Surgical USD 85.1M 6.2M Mar/2026
J&J USD 2.27 0.13 Jun/2026
Medtronic USD 114M 23M Jan/2025
Merck USD 35M 34M Mar/2026
Merit Medical Systems USD 3.9M 4K Mar/2026
Pfizer USD -0.04 115M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026
Stryker USD 38M 9M Mar/2025
Tandem Diabetes Care USD 3.63M 610K Mar/2026
Vertex Pharmaceuticals USD 120.6M 5.8M Jun/2026
Zoetis USD 21M 4M Mar/2026